Results 171 to 180 of about 230,503 (220)

Control of nasal obstruction in perennial allergic rhinitis

Current Opinion in Allergy and Clinical Immunology, 2004
Nasal obstruction, the cardinal symptom of persistent (perennial) allergic rhinitis, is one of the most common symptoms encountered in primary care and in specialist clinics. It is difficult to quantify by clinical examination, and, hence, objective assessment of the nasal airway is critical to rhinologic research.
De-Yun, Wang, Md Tanveer, Raza, Bruce R, Gordon   +2 more
openaire   +2 more sources

The anticholinergic treatment of allergic perennial rhinitis

Journal of Allergy and Clinical Immunology, 1992
Anticholinergic agents have been used for nonallergic rhinitis expressly to control rhinorrhea. In allergic rhinitis, rhinorrhea can be extremely troublesome and unresponsive to traditional pharmacotherapeutic rhinitis treatments. Anticholinergic agents, through their specific ability to decrease nasal secretory response, should have beneficial effects
openaire   +2 more sources

Bepotastine besilate for the treatment of perennial allergic rhinitis

Expert Opinion on Pharmacotherapy, 2018
Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the Food and Drug Administration (FDA) for the treatment of allergic conjunctivitis. In other countries, the oral presentation of BB is widely used for the improvement of symptoms of allergic rhinitis (AR) as well as ...
Ismael, Carrillo-Martin, Alexei, Gonzalez-Estrada, Ves, Dimov   +2 more
openaire   +2 more sources

Oral Vasoconstrictors in Perennial Non‐Allergic Rhinitis

Allergy, 1982
Nasal airway resistance and nasal symptoms were evaluated in patients with perennial non‐allergic rhinitis before and after vasoconstrictory drugs and placebo taken orally. The patients were partly selected; these suffering mainly from nasal obstruction being tested.
P, Broms, L, Malm
openaire   +2 more sources

Non-Allergic Perennial Rhinitis

2018
Non-infectious rhinitis can broadly be subdivided into two subclasses, allergic and non-allergic rhinitis, depending predominantly on whether or not an allergic aetiology is implicated. The term 'non-allergic rhinitis' is commonly applied to a diagnosis of any nasal condition in which the symptoms are identical to those seen in allergic rhinitis but an
Jameel Muzaffar, Shahzada K. Ahmed
openaire   +1 more source

Polymorphism of the CD14 gene in perennial allergic rhinitis

International Journal of Pediatric Otorhinolaryngology, 2006
Allergic diseases have strong genetic backgrounds. Recently, a C-T polymorphism in the promoter region of CD14 has been associated with phenotypes of atopy in some populations. The aim of this study was to investigate the association of CD14/-159 polymorphism with total serum IgE levels and number of positive skin prick tests in Korean population with ...
Hee Joon, Kang, Yun-Mi, Choi, Sung Won, Chae, Jeong-Soo, Woo, Soon Jae, Hwang, Heung-Man, Lee   +5 more
openaire   +2 more sources

Allergic rhinitis: A perennial burden

Practice Nursing, 1996
The seriousness of allergic rhinitis and its impact on patients' lives is grossly underestimated. Glenis Scadding discusses the new guidelines and how practice nurses can ease the burden.
openaire   +1 more source

Eosinophil Cationic Protein in Perennial Allergic Rhinitis

Auris Nasus Larynx, 1995
For a quantitative investigation of eosinophil activation in perennial allergic rhinitis, eosinophil cationic protein (ECP) concentrations were measured by a radioimmunoassay in serum, nasal secretions (ECPWN) and in the supernatant of these nasal secretions (ECPsup) obtained from normal subjects and allergic patients.
K, Hisamatsu, T, Ganbo, R, Goto, T, Nakazawa, Y, Murakami   +4 more
openaire   +2 more sources

Ebastine in perennial allergic rhinitis.

Annals of allergy, 1992
Oral ebastine, 10 mg once daily for seven days, and placebo were compared as treatment for active perennial allergic rhinitis in 151 patients in a multicenter, randomized, double-blind trial. Ebastine treatment produced a significant reduction in the incidence and severity of most symptoms associated with perennial rhinitis. Tolerability was similar in
C, Picado Vallés, A, Cadahia García, A, Cisteró Bahima, L, Cano Cantudo, A, Sanz Amaro, J M, Zayas Sanza   +5 more
openaire   +1 more source

The pharmacological basis for the treatment of perennial allergic rhinitis and non‐allergic rhinitis with topical corticosteroids

Allergy, 1997
The currently available respiratory topical corticosteroids are all effective at reducing the nasal symptoms of itch, sneezing, rhinorrhoea and obstruction associated with allergic rhinitis. The mechanism of action of corticosteroids is related to their anti‐innammatory activities.
openaire   +2 more sources